new tirzepatide medication FDA approves version of diabetes drug Mounjaro to be sold for weight loss Eli Lilly weight-loss drug appears

How Tirzepatide Works Tirzepatide activates both GIP and GLP-1 receptors, with a stronger emphasis on GIP receptor activation

Variations in study design, diagnostic criteria, and population characteristics limited comparability and prevented meta-analysis

Here are the facts about Wegovy and Mounjaro.

When to take the plunge and what surgeon to choose is detailed in this article.

By examining these varied environments, we can gain insights into how market dynamics might develop as subsequent waves of countries lose exclusivity, informing strategies for competitive positioning in future markets

Discover why older Americans are abandoning GLP-1 drugs for weight loss, citing high costs, side effects, muscle loss, and inadequate monitoring